ENSC
Price
$1.11
Change
-$0.01 (-0.89%)
Updated
Dec 24 closing price
Capitalization
4.03M
Intraday BUY SELL Signals
RLMD
Price
$4.60
Change
+$0.11 (+2.45%)
Updated
Dec 24 closing price
Capitalization
337.33M
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENSC vs RLMD

Header iconENSC vs RLMD Comparison
Open Charts ENSC vs RLMDBanner chart's image
Ensysce Biosciences
Price$1.11
Change-$0.01 (-0.89%)
Volume$28.66K
Capitalization4.03M
Relmada Therapeutics
Price$4.60
Change+$0.11 (+2.45%)
Volume$335.4K
Capitalization337.33M
ENSC vs RLMD Comparison Chart in %
ENSC
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ENSC vs. RLMD commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and RLMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ENSC: $1.11 vs. RLMD: $4.60)
Brand notoriety: ENSC and RLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 12% vs. RLMD: 24%
Market capitalization -- ENSC: $4.03M vs. RLMD: $337.33M
ENSC [@Biotechnology] is valued at $4.03M. RLMD’s [@Biotechnology] market capitalization is $337.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 1 FA rating(s) are green whileRLMD’s FA Score has 0 green FA rating(s).

  • ENSC’s FA Score: 1 green, 4 red.
  • RLMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both ENSC and RLMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 4 TA indicator(s) are bullish while RLMD’s TA Score has 4 bullish TA indicator(s).

  • ENSC’s TA Score: 4 bullish, 3 bearish.
  • RLMD’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ENSC and RLMD are a good buy in the short-term.

Price Growth

ENSC (@Biotechnology) experienced а -1.77% price change this week, while RLMD (@Biotechnology) price change was +14.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

RLMD is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLMD($337M) has a higher market cap than ENSC($4.03M). RLMD YTD gains are higher at: 784.615 vs. ENSC (-86.364). ENSC has higher annual earnings (EBITDA): -10.95M vs. RLMD (-57.84M). RLMD has more cash in the bank: 13.9M vs. ENSC (1.67M). RLMD has less debt than ENSC: RLMD (256K) vs ENSC (388K). ENSC (0) and RLMD (0) have equivalent revenues.
ENSCRLMDENSC / RLMD
Capitalization4.03M337M1%
EBITDA-10.95M-57.84M19%
Gain YTD-86.364784.615-11%
P/E Ratio0.02N/A-
Revenue00-
Total Cash1.67M13.9M12%
Total Debt388K256K152%
FUNDAMENTALS RATINGS
ENSC vs RLMD: Fundamental Ratings
ENSC
RLMD
OUTLOOK RATING
1..100
508
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9434
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
6543

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENSC's Valuation (28) in the null industry is somewhat better than the same rating for RLMD (74). This means that ENSC’s stock grew somewhat faster than RLMD’s over the last 12 months.

ENSC's Profit vs Risk Rating (100) in the null industry is in the same range as RLMD (100). This means that ENSC’s stock grew similarly to RLMD’s over the last 12 months.

ENSC's SMR Rating (100) in the null industry is in the same range as RLMD (100). This means that ENSC’s stock grew similarly to RLMD’s over the last 12 months.

RLMD's Price Growth Rating (34) in the null industry is somewhat better than the same rating for ENSC (94). This means that RLMD’s stock grew somewhat faster than ENSC’s over the last 12 months.

ENSC's P/E Growth Rating (76) in the null industry is in the same range as RLMD (100). This means that ENSC’s stock grew similarly to RLMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENSCRLMD
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ENSC
Daily Signal:
Gain/Loss:
RLMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ISPC0.390.01
+1.89%
iSpecimen Inc
BBY69.740.16
+0.23%
Best Buy Company
WB10.08N/A
N/A
Weibo Corp
FNGR1.42-0.01
-0.70%
FingerMotion
FLOC18.02-0.20
-1.10%
Flowco Holdings Inc

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with RLMD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then RLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
-0.89%
RLMD - ENSC
38%
Loosely correlated
+2.45%
MLLCF - ENSC
37%
Loosely correlated
N/A
ITRM - ENSC
36%
Loosely correlated
-7.89%
RZLT - ENSC
35%
Loosely correlated
+13.22%
ATOS - ENSC
34%
Loosely correlated
+0.32%
More

RLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with ENSC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+2.45%
ENSC - RLMD
38%
Loosely correlated
-0.89%
SYRE - RLMD
36%
Loosely correlated
-0.54%
PLUR - RLMD
34%
Loosely correlated
-0.31%
PRTC - RLMD
31%
Poorly correlated
+0.03%
AVXL - RLMD
31%
Poorly correlated
-0.27%
More